arctigenin has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, X; Dai, J; Fang, X; Han, J; Liu, L; Qin, G; Wang, G; Xiang, R; Yang, S; Zhao, Z; Zhou, Y | 1 |
| Feng, Q; Sun, BC; Xia, WK | 1 |
2 other study(ies) available for arctigenin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Arctigenin mitigates insulin resistance by modulating the IRS2/GLUT4 pathway via TLR4 in type 2 diabetes mellitus mice.
Topics: Animals; Diabetes Mellitus, Type 2; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Toll-Like Receptor 4 | 2023 |
[Protective effect of arctigenin in GK rats combined with hypertension macroangiopathy].
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Drugs, Chinese Herbal; Furans; Humans; Hypertension; Lignans; Male; Rats; Rats, Wistar | 2015 |